216581-47-4

Basic information

• Product Name: 6-methyl-4-oxo-3-phenylmethoxypyran-2-carboxylic acid
• Synonyms: 6-methyl-4-oxo-3-phenylmethoxypyran-2-carboxylic acid
• CAS NO: 216581-47-4
• Molecular Formula: C₁₄H₁₂O₅
• Molecular Weight: 260.24208
• Mol File: 216581-47-4.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 6-methyl-4-oxo-3-phenylmethoxypyran-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 6-methyl-4-oxo-3-phenylmethoxypyran-2-carboxylic acid(216581-47-4)
• EPA Substance Registry System: 6-methyl-4-oxo-3-phenylmethoxypyran-2-carboxylic acid(216581-47-4)

Safety Data

• Hazardous Substances Data: 216581-47-4(Hazardous Substances Data)

Usage

General Description

6-methyl-4-oxo-3-phenylmethoxypyran-2-carboxylic acid is a chemical compound with a complex structure that includes a pyran and carboxylic acid group. The presence of a methyl group and a phenylmethoxy group add to its structural diversity. 6-methyl-4-oxo-3-phenylmethoxypyran-2-carboxylic acid is a synthetic organic molecule with potential applications in medicinal chemistry and drug development. Its unique structure suggests that it may have biological activity, but further research is needed to determine its specific properties and potential uses. Its complex structure and potential medicinal applications make it an interesting target for further study and exploration in the field of organic chemistry.

Upstream product

• 7758-19-2 sodium chlorite 
• 5329-14-6 aminosulfonic acid 
• 216581-46-3 2-formyl-3-benzyloxy-6-methyl-pyran-4(1H)-one 
• 216581-77-0 2-Hydroxymethyl-3-benzyloxy-6-methyl-pyran-4(1H)-one 
• 22639-17-4 2-hydroxymethyl-3-hydroxy-6-methyl-pyran-4(1H)-one 
• 644-46-2 allomaltol 
• 7559-81-1 chlorokojic acid 
• 501-30-4 5-hydroxy-2-(hydroxymethyl)-4H-pyran-4-one 

Downstream Products

• 870102-36-6 AM-2S 
• 1064077-28-6 3-(benzyloxy)-6-methyl-4-oxo-1,4-dihydropyridine-2-carboxylic acid 
• 922159-37-3 C₁₄H₁₂FNO₄ 
• 932024-46-9 3-benzyloxy-6-methylpyran-4(1H)-one-2-carboxy-N-(4-methoxybenzylamide) 
• 922159-35-1 C₂₁H₁₈FNO₄ 
• 216581-60-1 1,6-dimethyl-3-benzyloxy-pyridin-4(1H)-one-2-carboxy-(N-methyl)-amide 
• 444103-11-1 3-(benzyloxy)-N,N-diethyl-1,6-dimethyl-4-oxo-1,4-dihydropyridine-2-carboxamide 
• 887774-72-3 3-benzyloxy-1-cyclopropyl-6-methyl-4-oxo-1,4-dihydro-pyridine-2-carboxylic acid 
• 347393-45-7 1,6-dimethyl-3-benzyloxy-pyridin-4(1H)-one-2-carboxy-(N-benzyl)-amide 
• 347393-41-3 3-benzyloxy-6-methyl-pyran-4(1H)-one-2-carboxy-(N-benzyl)-amide 
• 347393-46-8 1,6-dimethyl-3-benzyloxy-pyridin-4(1H)-one-2-carboxy-(N-phenyl)-amide 
• 347393-47-9 1,6-dimethyl-3-benzyloxy-pyridin-4(1H)-one-2-carboxy-(N-3'-pyridyl)-amide 
• 216581-64-5 1,6-dimethyl-3-benzyloxy-pyridin-4(1H)-one-2-carboxy-(N-2'-hydroxyethyl)-amide 
• 216581-63-4 1,6-dimethyl-3-benzyloxy-pyridin-4(1H)-one-2-carboxy-(N-2'-methoxyethyl)-amide 

Relevant articles and documents

Synthesis, molecular modelling and biological studies of 3-hydroxy-pyrane-4-one and 3-hydroxy-pyridine-4-one derivatives as HIV-1 integrase inhibitors

Background: Despite the progress in the discovery of antiretroviral compounds for treating HIV-1 infection by targeting HIV integrase (IN), a promising and well-known drug target against HIV-1, there is a growing need to increase the armamentarium against

MULTIDENTATE PYRONE-DERIVED CHELATORS FOR MEDICINAL IMAGING AND CHELATION

Provided herein are chelating agents and metal chelates that are useful in diagnostic and therapeutic applications. The uses of metal chelates provided herein include their use as contrast agents in medical imaging modalities, such as magnetic resonance imaging (MRI).

ZINC-BINDING GROUPS FOR METALLOPROTEIN INHIBITORS

The present invention relates to metalloprotein inhibitors comprising: a. an organic backbone molecule (Pep) and at least one zinc binding group (ZBG) covalently attached thereto; or b. at least one ZBG substituted by a side chain that comprises one or more amido and/or amino moieties, wherein the ZBG is of formula (I): wherein the wavy line represents a Pep molecule or a side chain that is an R3 or an R4 group which comprises one or more amido and/or amino moieties, and wherein X is O or S and each R1, R2, R3, and R4 is individually hydrogen or an organic radical. The metalloprotein inhibitors are useful for preventing or treating a pathological disease, condition, or symptom that is associated with pathological metalloprotein activity and/or that is alleviated by inhibition of said activity.